Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MediNet Group's ROE % for the quarter that ended in Mar. 2026 was -64.39%. MediNet Group's PB Ratio for the quarter that ended in Mar. 2026 was 2.69.
MediNet Group's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -23.94%.
MediNet Group ROE % Adjusted to Book Value Related Terms
MediNet Group ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for MediNet Group's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08161 vs HCA, THC, DVA: ROE % Adjusted to Book Value Comparison
For the Medical Care Facilities subindustry, MediNet Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MediNet Group ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MediNet Group's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where MediNet Group's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -23.94% mean?
MediNet Group (HKSE:08161) has a ROE % Adjusted to Book Value of -23.94% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MediNet Group and its competitors.
Is MediNet Group's ROE % Adjusted to Book Value too high?
MediNet Group's current ROE % Adjusted to Book Value is -23.94%. Overall, MediNet Group has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MediNet Group's ROE % Adjusted to Book Value compare to HCA and THC?
MediNet Group's ROE % Adjusted to Book Value of -23.94% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MediNet Group and its competitors. MediNet Group's current ROE % Adjusted to Book Value is -23.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediNet Group stock overvalued right now?
Based on GuruFocus' analysis, MediNet Group (HKSE:08161) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.29, compared to a current price of HK$0.66 — trading 127.6% above its estimated fair value. The current ROE % Adjusted to Book Value is -23.94%. MediNet Group's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For MediNet Group (HKSE:08161), the current ROE % Adjusted to Book Value is -23.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MediNet Group (HKSE:08161) Overvalued in 2026?
Based on GuruFocus' analysis, MediNet Group stock appears to be overvalued.
The current stock price of HK$0.66 is trading 127.6% above its estimated GF Value™ of HK$0.29.
GuruFocus considers MediNet Group to be Significantly Overvalued.
Key valuation signals for HKSE:08161:
ROE % Adjusted to Book Value: -23.94%
GF Value™: HK$0.29 vs. price of HK$0.66 (127.6% above fair value)
No single metric tells the full story. See the HKSE:08161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MediNet Group Ltd is a provider of corporate healthcare solutions in Hong Kong. The company's operating segment includes the Dental business and the Medical business. The Dental segment offers dental solutions and dental services by dental clinics owned and operated by the group. Its Medical segment provides outpatient general services and men's health treatment services. It offers services to both plan members and self-paid patients. Geographically, the company generates the majority of its revenue from Hong Kong.
43GF Score
Get the complete analysis for HKSE:08161
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08161 has been successfully added to your 
